Iris Monitoring System

Connectivity, monitoring and intelligence for process tanks / process monitoring

IRIS Monitoring System for the data collection of tomorrow

Articles in the range Iris Monitoring System

Automation Food industry Pharmaceutical

IRIS 2021 hardware

The hardware component for modern process monitoring, condition monitoring and maintenance management.

Technical information:
  • A8 CPU with 1 GHz
  • Linux RT operating system
  • 4 GB flash memory
  • 512 MB RAM memory
  • Mini SPS with Colossus software
  • 2x Ethernet ports
  • 1x USB 3.0 Port
  • 1x serial port
  • 1x SD Port
  • 1x slot for plug-in module
  • 4x analogue inputs (expandable)
  • 20x digital inputs (expandable)
  • 4x digital / analogue outputs
  • GSM / WLAN / Bluetooth / OPC-UA
  • Modular expansion
  • Top hat rail assembly
  • Can be retrofitted in every machine and tank


Automation Food industry Pharmaceutical

IRIS visualisation & software

Our solutions for visualising your monitoring

We offer two versions here.

  1. The cloud version using GSM/wireless communications
  2. In-house server integration via WLAN, Ethernet, Bluetooth or OPCUA Standard


The benefits of the IRIS Monitoring System:
  • Simultaneous monitoring of multiple devices and machines
  • Objective and automatic data collection
  • Identification of alarm and warning signals
  • Automatic alarm via email, smartwatch or warning light
  • Creation of batch records
  • Paperless access to tank documentation
  • Paperless access to work instructions and PDF documents
  • Monitoring of changes to parts and full load
  • User accounts with access rights
  • Maintenance analyses
  • Audit log
  • Data export
  • Data collection in the event of power outages using a UPS
  • Transfer via OPCUA for ERP systems

Dear Sir or Madam,
Dear Mr Weinert,

On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.

Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE